San Francisco, California
London, United Kingdom
Changing The Practice And Perception Of Psychiatry: Delivering Optimal Care In An Integrated Setting
Arizona Psychiatric Society
Annual Spring Meeting
Saturday, April 12, 2014
Wild Horse Pass Casino and Resort
5040 Wild Horse Pass Boulevard
Chandler, Arizona 85048
Jointly Sponsored by
American Psychiatric Association
and the Arizona Psychiatric Society
In conjunction with
the Arizona Chapter of the
Academy of Child and Adolescent Psychiatry
SCHEDULE OF EVENTS
7:00 – 7:50 Registration, Continental Breakfast, and Visit Exhibitors
7:50 – 8:00 Welcome and Opening Remarks – Joanna K. Kowalik, MD, MPH
8:00 – 8:45 Alzheimer’s Prevention: Pipedream or Possibility
Pierre N. Tariot, MD
Director, Banner’s Alzheimer’s Institute
8:45 – 9:00 Questions and Answers with Dr. Tariot
9:00 – 10:00 Integrated Mental Health Care: Closing the Gap Between What We Know and What We Do
Anna Ratzliff, MD, PhD
Assistant Professor; Associate Director for Education, Division of Integrated Care & Public Health
Department of Psychiatry & Behavioral Sciences
University of Washington, AIMS Center
10:00 – 10:15 Questions and Answers with Dr. Ratzliff
10:15 – 10:35 Coffee Break and Visit Exhibitors
10:35 – 11:35 Mood Dysregulation in Children: What’s Bipolar and What’s Not
Steven R. Pliszka, MD
Professor and Interim Vice Chair
Chief, Division of Child and Adolescent Psychiatry
The University of Texas Health Science Center at San Antonio
11:35 – 11:50 Questions and Answers with Dr. Pliszka
11:50 – 12:30 Lunch
1:00 – 1:20 Legislative Update
Joseph F. Abate, Esq.
Lobbyist, Arizona Psychiatric Society
Of Counsel – Curtis, Goodwin, Sullivan, Udall & Schwab, P.L.C.
1:20 – 1:30 Legislative Update Q&A
1:30 – 2:00 Update from the State of Arizona Division of Behavioral Health Services
Steven Dingle, MS, MD
Chief Medical Officer, Arizona Division of Behavioral Health Services
State of Arizona Department of Health Services
2:00 – 2:15 Questions & Answers with Dr. Dingle
2:15 – 3:15 Diagnostic Principles in Psychopharmacology
Pedro L. Delgado, MD
Professor of Psychiatry, Dielmann Distinguished Chair in Psychiatry, School of Medicine, University of Texas Health Sciences Center at San Antonio
3:15 – 3:30 Questions and Answers with Dr. Delgado
3:30 – 3:50 Break / Visit Exhibitors
3:50 – 4:35 Pathophysiology of Alcohol Withdrawal: Novel Treatments Beyond Benzodiazepines
José R. Maldonado, MD, FAPM, FACFE
Associate Professor of Psychiatry, Internal Medicine, Surgery, Emergency Medicine & Law; Medical Director, Psychosomatic Medicine Service; Chief, Medical Psychotherapy Clinic, Stanford School of Medicine
4:35 – 4:50 Questions and Answers with Dr. Maldonado
4:50 – 5:35 Palliative Care and Psychiatry: Providing Supportive Care to the Palliative Patient
Karen Weihs, MD
Professor of Psychiatry
Medical Director, Psychosocial Oncology Services
University of Arizona Cancer Center, North Campus
5:35 - 5:50 Questions and Answers with Dr. Weihs
GENERAL LEARNING OBJECTIVES
At the conclusion, the attendee should be able to:
a. Apply collaborative care principles to current clinical practice in one or more of the educational topics addressed in the Annual Meeting.
b. Effectively and efficiently manage psychiatric conditions presented through updates in standards of care.
c. Learn new techniques, both pharmacological and psychosocial, and apply them towards the improvement of patient care.
d. Keep abreast of current and new issues with in-depth presentations by authorities in these fields.
e. Effectively advocate for legislature that will result in improved patient standards of care in the mental health community and effectively advocate against legislature that will harm patient standards of care.
ARIZONA PSYCHIATRIC SOCIETY OFFICERS
Joanna K. Kowalik, MD, MPH, President
Payam M. Sadr, MD, FAPA, President-Elect
Roland Segal, MD, Vice President
Gurjot K. Marwah, MD, Treasurer
Aaron R. Wilson, MD, Secretary
Tariq M. Ghafoor, MD, Immediate Past President
Gretchen B. Alexander, MD, Past President
Michael E. Brennan, MD, DLFAPA, Past President
Jehangir B. Bastani, MD, DLFAPA, APA Assembly Representative
Felicitas Koster, DO, Resident-Fellow Member Representative
It is the policy of the APA to comply with the ACCME Standards for Commercial Support of CME. All faculty participating in sponsored or jointly sponsored programs by the APA are required to disclose to the program audience any real or apparent financial relationships with commercial interests related to the content of their presentation(s). Faculty also are responsible for disclosing any discussion of off-label or investigational use of a product.
Drs. Dingle, Maldonado, and Weihs and Messr. Abate have disclosed that neither they nor any member of their immediately family has any relevant financial relationship with any commercial interest, and they will not discuss unapproved uses of a commercial product, or investigational use of a product not yet approved for this purpose, during their presentation at this educational activity. Dr. Tariot has disclosed that he has relevant financial relationships through stock/other financial options in Adamas; consultant with AC Immune, California Pacific Medical Center, Chase Pharmaceuticals, CME Inc., Medavante, Merz, Otsuka, Sanofi-Aventis, Avanir, Avid, Bristol Meyer Squibb, Cognoptix, Janssen, Eli Lilly, Merck & Co., Roche, and Abvie; grant or research support from Avanir, Avid, Bristol Meyer Squibb, Cognoptix, GlaxoSmithKline, Janssen, Eli Lilly, Medivation, Merck & Co., Roche, AstraZeneca, Baxter Healthcare Corp., Functional Neuromodulation (f(nm)), GE, Genentech, Pfizer, Targacept, Toyama, NIA< Arizona Department of Health Services; employee of Banner Alzheimer’s Institute; and is listed as a contributor to a patent owned by the University of Rochester, “Biomarkers of Alzheimer’s Disease,” and will not discuss unapproved uses of a commercial product, or investigational use of a product not yet approved for this purpose, during his presentation at this educational activity. Dr. Ratzliff has disclosed she is contracted to Community Health Plan of Washington for psychiatric consultation, and will not discuss unapproved uses of a commercial product, or investigational use of a product not yet approved for this purpose, during her presentation at this educational activity. Dr. Pliszka has disclosed he is a consultant to Shire and has served as expert witness for Ortho McNeil, Janssen, and Eli Lilly, and that he will discuss unapproved uses of a commercial product, or investigational use of a product not yet approved for this purpose, during his presentation at this educational activity. Dr. Delgado has disclosed he has served as a consultant to Pfizer, and will not discuss unapproved uses of a commercial product, or investigational use of a product not yet approved for this purpose, during his presentation at this educational activity.
Arizona Psychiatric Society Planning Committee
Joanna K. Kowalik, MD, MPH, Program Director
Planning Committee Members:
Gretchen B. Alexander, MD
Michael E. Brennan, MD, DLFAPA
Emerson B. Bueno, MD, FAPA
Tariq M. Ghafoor, MD
Amie E. Kafer, DO
Elise L. Leonard, MD
Payam M. Sadr, MD, FAPA
Monica Taylor-Desir, MD, MPH
Kytja Voeller, MD
Ole J. Thienhaus, MD, DFAPA
Teri Harnisch (Staff)
Planning Committee Disclosures
Drs. Alexander, Brennan, Bueno, Ghafoor, Kafer, Kowalik, Leonard, Sadr, Taylor-Desir, Thienhaus, and Voeller, and Mrs. Harnisch have disclosed neither they nor any member of their immediate family has any financial relationship with any commercial interest as well as they will disclose any conflict of interest that may arise during the planning of CME activities and rescue themselves from any discussions where a potential bias could exist.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint Sponsorship of the American Psychiatric Association (APA) and the Arizona Psychiatric Society. The APA is accredited by the ACCME to provide continuing medical education for physicians.
The American Psychiatric Association designates this live educational activity for a maximum of 8.0 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Psychiatric physicians, physicians of other specialties, residents, and nurses.
An evaluation is provided for review and comments on the presentations. CME Certificates will be available for participants at the end of the program.
PRESENTATIONS AND HAND-OUTS
The speaker presentation materials will be made available in electronic format in single slide view to enhance readability. If you would like a copy of one or all of the presentations in electronic format, please notify Teri (email@example.com, 602-347-6903) with your preferred e-mail address and which presentation materials are requested.
The Arizona Psychiatric Society would like to thank the following companies for their participation and support of the Annual Spring Meeting.
[ To come ]
When & Where
Arizona Psychiatric Society
Contact firstname.lastname@example.org with any questions. Hope to see you at the event!